Survival in Alpha-1 Antitrypsin (A1AT) Deficient Lung Transplant Recipients by Use of A1AT Augmentation Therapy

Purpose: While Lung Transplant (LT) is a key treatment for patients with Alpha-1 Antitrypsin Deficiency (A1ATD), there is currently insufficient evidence to determine whether these recipients should receive A1AT augmentation therapy post-LT.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , J. Ruck, A. Casillan, R. Riojas, P. Shah, J. Ha, S. Strout, A. Massie, D. Segev, C. Merlo, E. Bush Source Type: research